SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Zydus Lifesciences inks pact to amend clauses of JVA with Bayer

27 Jul 2023 Evaluate

Zydus Lifesciences has signed an agreement to amend certain clauses of the joint venture agreement (JVA) with Bayer (South East Asia) PTE, one of the companies of the Bayer group. An agreement to amend certain clauses of the JVA to enable participation in tenders of some government institutions / public sector undertakings for some products through an affiliate entity of a JV Partner.

Earlier, the company had entered into an JVA with Bayer (South East Asia) PTE dated January 28, 2011 and pursuant to which the JV Partners formed a joint venture company i.e. Bayer Zydus Pharma.  

Zydus Lifesciences (formerly known as Cadila Healthcare) is an India-based pharmaceutical company. 

Zydus Lifesciences Share Price

942.55 3.35 (0.36%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×